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Abstract 
INTRODUCTION AND OBJECTIVES: Assessing the severity of upper tract urothelial 
carcinoma (UTUC) has been difficult because of inadequate biopsy specimens. Additional 
predictive parameters of disease stage would be useful when deciding a treatment plan; it has 
been suggested that preoperative hydronephrosis can be a surrogate. We examined the 
relationship between preoperative ipsilateral renal obstruction identified by imaging with final 
pathologic stage after nephroureterectomy (NU) for UTUC. We then analyzed those patients 
with ipsilateral renal obstruction and examined if tumor location is associated with an advanced  
pathologic stage.  
 
 METHODS: Patients who underwent NU for UTUC between the years 2001 to 2013 were 
analyzed and relevant staging studies and pathology were reviewed. Criteria for ipsilateral renal 
obstruction were defined by the presence of a delayed nephrogram on CT scan, renal cortical 
atrophy with associated hydronephrosis on cross-sectional imaging, and/or >10% split  
function discrepancy on nuclear renal scintigraphy with associated hydronephrosis.  
 
 RESULTS: Eighty-two patients met inclusion criteria; 26/82 (31.7%) had locally advanced 
disease (pT3/T4), while 56/82 (63.4%) had organ-confined (≤ pT2) disease. Of the patients with 
pT3/T4 disease, 10/26 (38.5%) demonstrated radiographic evidence of functional obstruction of 
the ipsilateral renal unit; similarly, in patients with ≤ pT2 disease, 21/56 (37.5%) demonstrated 
ipsilateral renal obstruction (p=0.93). Of the patients with ipsilateral renal obstruction, in those 
patients with pT3/T4 disease, 7/10 (70.0%) had ureteral tumor involvement while 9/21 (42.9%) 
patients with ≤ pT2 disease had tumor in the ureter (p=0.25).  
 
 CONCLUSIONS: This study suggests that renal obstruction by radiographic analysis does not 
always predict advanced stage. Additionally, there is a trend toward advanced stage when a 
patient has radiographic evidence of ipsilateral renal dysfunction and a ureteral tumor. 
 
 
 
 
Introduction 
 Upper tract urothelial carcinoma (UTUC) is a rare entity with respect to other 
genitourinary (GU) malignancies. It is reported that it accounts for approximately 5% of renal 
and urothelial tumors.[1]  In comparison to other GU malignancies, according to the American 
Cancer Society statistics for the United States in 2014, there will be approximately 6500-7000 
new cases of UTUC in comparison to 233,000 prostate, 75,000 bladder, and 8800 testis cancer 
patients. [2] 
 The gold standard for the treatment of UTUC is radical nephroureterectomy (NU) with 
bladder cuff excision. However in those patients who are surgically unfit, have a solitary kidney, 
bilateral UTUC, or chronic kidney disease, endoscopic management may be an alternative to 
preserve as much functioning nephron as possible; additionally, endoscopic management has 
been used electively in patients with low grade, focal UTUC and a normal contralateral kidney. 
It has also been shown that disease specific survival has a poorer outcome in those with chronic 
kidney disease.[3] 
 Given that architectural preservation cannot be achieved with sampling of upper tract 
tumors, diagnosis and staging currently employ a multimodal approach of the following: 
ureteroscopy with direct visualization and biopsy, abdominal imaging via computed tomography 
(CT) or magnetic resonance imaging (MRI) to identify direct tumor extension, and endoluminal 
ultrasound, where available, which also may help to identify transmural involvement. 
Unfortunately, each modality has variable accuracy in predicting grade and stage and currently 
most treatment decisions are based upon ureteroscopy and specimen retrieval for 
cytopathological analysis and three-dimensional imaging. [4-11]  
Recently, the presence of hydronephrosis associated with or without renal obstruction on 
preoperative imaging was associated with worse prognosis and advanced stage UTUC on NU. 
[13,14]  Additionally, delayed ipsilateral renal excretion in patients with ureteral tumors has been 
associated with decreased survival on univariate analysis. [15]  We sought to confirm this 
relationship with our own, single-institutional UTUC population. Additionally, realizing that 
UTUC may have a different prognosis dependent on tumor location, we sought to determine if 
the location of the primary tumor (renal pelvis/calyces versus ureter) changed this association.  
 
 
 Materials and Methods 
After obtaining IRB approval, a retrospective analysis of consecutive patients undergoing 
NU at our institution between 2001 and 2013 was performed.  
Each patient’s preoperative staging studies, which included three-dimensional imaging 
and preoperative ureteroscopic biopsies and specimen cytology, were examined. Some patients 
in whom a NU was planned also obtained a scintigraphic renal scan in order to determine 
differential renal function and the ability of a remaining renal unit to sustain adequate function.  
A subset of patients in whom UTUC was being managed initially with serial endoscopic 
evaluations was evaluated using the highest histologic grade of tumor that was recovered 
endoscopically.  Following surgery, the tissue specimens were examined for pathologic grade 
and stage in a multidisciplinary genitourinary pathology conference. Each patient’s preoperative 
radiographic images were reviewed. Functional renal obstruction on preoperative imaging was 
defined by one of 3 variables:  
1. Radiologic demonstration of delayed nephrogram unilaterally on CT scan as 
described by the radiologist; 
2. The interpretation of ipsilateral renal cortical thinning with hydronephrosis in 
comparison to the contralateral kidney as described by the radiologist; and/or 
3. >10% split function discrepancy on nuclear renal scan with associated 
hydronephrosis. 
 
Summary statistics (n and percent) were calculated for the sample pre-NU stage, NU, 
Ipsilaterality, pathology stage, node status, symmetry, and change in staging. The relationship 
between pre-operative URS path grade and NU tumor stage was investigated in a few ways.  
Concordance was calculated between the two measures and agreement was assessed using the 
Kappa statistic.  Predictive power of the pre-op URS path stage on NU tumor stage was assessed 
using the Receiver Operating Characteristic under the curve (ROC AUC) from a logistic 
regression model.  A contingency table of ipsilateral decrease in renal function versus pathologic 
stage of UTUC was construction and a Pearson’s Chi-squared test used to assess the relationship 
of the two. 
 
Results 
We identified 82 patients who underwent NU. Seventy-five patients had a laparoscopic 
radical NU procedure, 7 had an open radical NU, and 3 patients attempted laparoscopically were 
converted to open. The mean age of the patient cohort was 69.2  +/- 11.2 years (33-95), as shown 
in Table 1. Laterality was evenly distributed: 41 right side moieties and 42 left side with 1 patient 
having a bilateral nephroureterectomy. The mean creatinine at the time of surgery was 1.4 +/- 
0.95 mg/dL (0.6-6.9). 
On final pathology, 37 patients had low grade UTUC, defined as grade 1, grade 1-2, or 
grade 2. Forty-one patients had high grade disease, defined as grade 2-3, or grade 3. Four 
patients did not have pathologic grade available (Table 2).  For these, 2004 world health 
organization/International Society of Urological Pathology WHO/ISUP classification of tumors 
of urinary tract were used. 
One patient did not have preoperative ureteroscopic biopsy grade information. The 
ureteroscopic biopsy grade correlated with final pathologic grade for the majority of patients. 
When comparing preoperative ureteroscopic biopsy grade to final pathologic grade, 54/81 (67%) 
of patients had identical tumor grade correlation between ureteroscopic and NU pathology. In 
18/81 patients (22%), the tumor grade was upgraded from low grade to high grade on final 
surgical pathology, and 9/81 (11%) of patients were downgraded from high ureteroscopic biopsy 
grade to low grade on final surgical pathology (Table 2).  
 Final pathologic stage information is shown in Table 3. Four patients had no evidence of 
disease (pT0), 29 patients had organ confined disease (pT1/T2), and 26 patients had locally 
advanced disease (pT3/T4).  The ability of ureteroscopic grade to predict final pathologic stage 
was next examined.  Positive prediction was concluded if there was high grade ureteroscopic 
cytology and advanced pathologic stage (≥ pT3), or low grade ureteroscopic cytology and organ 
confined disease (<pT3).  Stage correlation overall was 42/73 (57.5%) of patients. Low grade 
ureteroscopic grade and pT2 or less disease correlated to 30/47 (63.8%) of patients. High grade 
ureteroscopic grade and pT3 or greater stage showed a 12/26 (46.1%) correlation. Nine patients 
were omitted from this calculation because of the lack of preoperative ureteroscopic grade or if 
the patient had carcinoma in situ, CIS (5 patients) as the only pathologic diagnosis (Table 3).  
 By utilizing our criteria for functional renal obstruction, we next analyzed our hypothesis. 
In total, 10 patients showed ipsilateral functional renal obstruction and ≥pT3 stage disease, while 
16 patients had no renal obstruction and ≥pT3 stage disease. Contrarily, 21 patients had an 
ipsilateral renal obstruction with organ confined (<pT3) stage, while 35 patients had no 
obstruction and <pT3 disease. Thus 38.46% (10/26) patients with pT3 or greater disease showed 
ipsilateral renal obstruction in comparison to 37.50% (21/35) patients showing ipsilateral renal 
obstruction and organ confined disease (p=0.9334) as shown in Table 4. Of the patients with 
obstruction and <pT2 disease, 8 had delayed nephrogram on three-dimensional imaging, 4 had 
hydronephrosis with cortical thinning, and 11 had decreased differential function and 
hydronephrosis n(2 patients met 2 separate criteria).  For those with >pT3 UTUC, none had 
delayed nephrogram, 3 had hydronephrosis with cortical thinning, and 7 had decreased 
differential function and hydronephrosis. 
 Of the patients with functional renal obstruction, patients staged at pT3 or greater, 7/10 
(70.0%) patients had ureteral involvement (Table 5). When compared to those patients with 
functional renal obstruction and staged at ≤pT2, 9/21 (42.9%) patients had ureteral involvement 
(p=0.252).   
 
Discussion 
 For UTUC, accurate clinical staging is vital to determine the proper course of surgical 
management, especially if endoscopic management, which is now considered appropriate for 
some patients who possess low grade disease and a normal contralateral kidney, is contemplated 
[16,17]  Currently, staging is limited to visual inspection via ureteroscopy with endoscopic biopsy 
and urine aspiration for cytopathological analysis. [4]  Keely et al. reported on grade correlation 
between ureteroscopic biopsies and final NU specimens.  Of those patients, 7/8 (88%) with low 
ureteroscopic biopsy grade were confirmed to have low grade disease on final surgical 
pathology. Additionally, for patients with high grade ureteroscopic biopsies, 11/12 (91.7%) had 
high grade tumors on final surgical pathology. In examining final pathologic stage, only 3/29 
(10%) of patients with low grade ureteroscopic biopsy had muscle invasive disease (pT2 or 
greater), while 8/12 (67%) of high grade tumors were muscle invasive. [5] In comparison, our 
data showed that ureteroscopic biopsy was not completely reliable, correlating with final surgical 
pathology in 42/73 (57.5%) patients; low grade and ≤pT2 stage correlation was 30/47(63.8%), 
and high grade to >pT3 stage correlation was 12/26 (46.1%).  It should be noted that the Keeley 
series was also from this institution, although predating the current series buy at least 10 years, 
and involving only one, as opposed to multiple, pathologists. 
Recent data from Brown et al. noted that a high grade endoscopic biopsy corresponded to 
locally advanced disease on final surgical pathology in only 30/71 (42%) of patients [12] This 
uncertainty further demonstrates the need for more accurate diagnostic measures to predict final 
pathologic stage on initial radiographic and endoscopic evaluation. Additionally, prediction of 
stage by retrograde pyelogram was shown to be poor in a study by Keeley et al., indicating only 
a 27% correlation between retrograde radiographic appearance and advanced disease. [10] Finally, 
comparison of the visual appearance alone of a UTUC tumor with histologic grade has also been 
shown to be unreliable. El-Hakim et al. found that 30% of 40 patients were inaccurately 
classified based on appearance alone. [6] 
Abdominal imaging also has controversial ability to accurately determine pathologic 
stage of UTUC.  Attempts to detect direct transmural tumor extension on multi-detector 
abdominal/pelvic CT (MDCT) scans, by examining ureteral wall thickness, loss of renal sinus 
fat, or abnormal adjacent fat parenchyma are unreliable in clinical practice. In a study conducted 
by Fritz et al., MDCT correctly identified only 4/6 (66%) of pT3 renal pelvis UTUC. In 
examining overall accuracy in tumor stage prediction, the study quoted 87.8% (36/41), with a 
sensitivity of only 66.6% (8/12) for detection of invasion of UTUC into adjacent tissues. [9] More 
recently, however, a study by Ng et al. determined a strong predictive value of preoperative 
hydronephrosis on three-dimensional imaging.  In this study, when stratifying by preoperative 
hydronephrosis versus no hydronephrosis, the estimated 5-year recurrence-free survival was 56% 
vs. 41% (P = 0.065), metastasis-free survival was 86% vs. 62% (P = 0.004), and cancer-specific 
survival was 94% vs. 66% (P = 0.001). [13]  
Although the accurate diagnosis of UTUC extent has obvious implication if nephron-
sparing surgery is contemplated, it also can affect the ultimate planning of surgical extirpation if 
the decision for NU has been made. Several studies have indicated the benefit for performing 
lymphadenectomy at time of surgery to improve disease specific survival. Roscigno et al. 
determined that nodal status is a significant predictor of disease specific survival and any patient 
expected to have pT2-pT4 tumors should undergo lymphadenectomy. [18]  Since pathologic stage 
is an important predictor of overall survival in UTUC, improved diagnosis of advanced disease 
would allow for more consideration for a lymphadenectomy, although many argue that a 
lymphadenectomy should be performed during all NU procedures. 
 More accurate knowledge and understanding of stage may also delineate a role for 
neoadjuvant chemotherapy. Although limited data on chemotherapy for UTUC exist, a cisplatin-
based regimen, as applicable for bladder cancer, can be extrapolated to advanced stage UTUC. 
For example, randomized phase III neoadjuvant cisplatin-based regimens for bladder cancer have 
shown survival benefits. [19] Application of bladder cancer neoadjuvant chemotherapy regimens 
to UTUC would putatively show similar benefits because of the common occurrence of locally 
advanced UTUC disease at diagnosis. [20]  In fact, recently the group from MD Anderson has 
demonstrated both overall and disease-specific survival benefit in patients with high-risk UTUC 
treated with neoadjuvant cisplatin-based chemotherapy. [21] 
 Our study suggests that radiographic analysis of UTUC patients does not always predict 
advanced stage of cancer. Our study showed 38.46% (10/26) patients with pT3 or greater disease 
had ipsilateral functional obstruction via radiographic analysis in comparison to 37.50% (21/35) 
patients with organ confined disease (p=0.9334). Thus, we cannot always rely upon functional 
renal obstruction as a prediction tool. This conclusion is in contrast to recent published studies 
correlating hydronephrosis and adverse pathologic features in NU for UTUC. [13,14]  Some 
differences in our study compared to these include the fact that we were not interested in only 
hydronephrosis but functional renal obstruction as defined by the criteria mentioned in the 
Methods section of this manuscript.  Additionally, Messer et al. in their multi-institutional 
analysis found hydronephrosis to be an independent predictor for muscle invasive UTUC (pT2) 
[14]; we instead were interested in predicting more advanced (> pT3) tumors.   
Another important observation of this study was the location of tumor and the pathologic 
stage of UTUC in those patients who had functional renal obstruction. In our cohort, 7/10 (70%) 
of patients with pT3/T4 disease with functional renal obstruction had ureteral involvement while 
only 9/21 (42.9%) of patients with ≤pT2disease and functional renal obstruction had ureteral 
involvement. Although not significant (p=0.252) this data suggest a trend towards advanced 
pathologic stage when a patient has radiographic evidence of functional renal obstruction caused 
by a ureteral tumor, as opposed to a renal tumor.  This correlation was indeed found to be 
significant by Ng et al. [13]  However, the impact of tumor location on patient survival in UTUC 
has recently been called into question. [22] 
The pathophysiologic mechanism for our observation is not clear, although we do 
propose one possible mechanisms to explain functional renal obstruction as a marker of locally 
advanced disease, particularly in patients with a ureteral tumor.  In the ureter, locally advanced 
tumors theoretically penetrate the muscularis propria, potentially diminishing peristaltic activity 
and thus causing obstruction, with hydronephrosis being the end result. Additionally, it has been 
our anecdotal experience that some advanced stage ureteral tumors present as dense strictures, 
proposing yet another mechanism for functional obstruction. For those with ipsilateral decrease 
in renal function and advanced stage, tumor location is shown in Table 5. 
 There are several limitations of our study, including its retrospective nature and 
incomplete data of all patients involved. Additionally, the disparity in relative renal function was 
set relatively arbitrarily, however the opinions of radiologists were sought for this purpose.  
Finally, a more ideal study design would involve a larger prospective evaluation with uniform 
preoperative imaging.  
 
Conclusions 
 When considering only moderate correlation between pathologic tumor grade on biopsy 
and pathologic stage from NU specimen, and the shortcomings of other utilized modalities in 
determining locally-advanced disease, this study did not find that renal obstruction by 
radiographic analysis can always predict an advanced stage of UTUC. However, a trend was 
noticed towards advanced pathologic stage when patient had functional renal obstruction and a 
ureteral tumor. This can have a great clinical impact, providing guidance when deciding between 
nephron-sparing approaches versus extirpative management of the renal unit for UTUC, the need 
for lymphadenectomy, and identification of candidates for neoadjuvant chemotherapy or 
enrollment in clinical trials.  
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